2019-2023 Competing in the Global HIV/AIDS Diagnostic Testing Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses are reviewed. The report provides the 5-year test volume and sales forecasts by country for HIV-1/2/Combo, HIVAg/HIV NAT, HTLV-I/II, Western Blot and other confirmatory tests performed in the following markets:

- Hospitals - Public Health Labs - Commercial/Private Labs
- Blood Banks - Physician Offices - Ambulatory Care Centers

For each country, in addition to the test volume and sales projections, the report presents the sales and market share estimates for major suppliers of AIDS tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies profiles leading suppliers and recent market entrants developing innovative technologies and products and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

I. Introduction
II. Worldwide Test Overview,
Technologies and Instrumentation
A. Background, Diagnostic Tests, Vaccines and Drugs
B. Instrumentation Review: Operating Characteristics,
Features and Selling Princes of Leading Infectious Disease
Automated and Semi-automated Analyzers
C. Emerging Infectious Disease Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Others
D. Personal Testing
III. Country Analyses: Sales and Volume Forecasts
IV. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
V. Design Criteria for Decentralized Testing Products
VI. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets

VII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VIII. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher/Life Technology
- Wallac/PE
- Wako

Global Immunodiagnostics Market, 2019-2023: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, 2019-2023--Clinical Chemistry, Drugs of Abuse, Endocrine Function, Immunoproteins, Special Chemistry, Therapeutic Drug Monitoring (TDM), Tumor Markers

This new report is a strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both centralized (hospitals, commercial laboratories), and POC/decentralized locations.

USD 27500 View Report

Canada Blood Typing, Grouping and Infectious Disease NAT Screening Market: Supplier Strategies, Volume and Sales Forecasts, Technology and Instrumentation Review, 2019-2023

This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities during the next five years, and assist industry executives in developing effective

USD 2750 View Report

Competing in the Global Drug of Abuse Testing Market: Supplier Shares, Segment Forecasts for 12 Assays, Growth Opportunities

This new 318-page report contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and

USD 8500 View Report

Competing in the Global Immunoprotein Testing Market: Supplier Shares, Segment Forecasts for 13 Assays, Growth Opportunities

This new 297-page report contains 72 tables and provides analysis of the global immunoprotein diagnostic market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles

USD 8500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available